“ Integrity, Honesty, Experience.

 

 

On April 7, 2005 the FDA asked Pfizer to voluntarily remove Bextra from the market due to studies showing an increased risk of cardiovascular adverse events and serious skin reactions (eg. toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiform).

 

The American Heart Association warns of a link between Bextra and heart attacks.

The AHA reported on November 9, 2004 that studies show that people using Bextra had twice (2x) the rate of heart attacks as those patients taking a placebo. Some doctors and scientists are calling Bextra potentially more dangerous than Vioxx - a similar drug pulled from the market in September 2004.

On December 23, 2004 the FDA released a public health advisory recommending the limited use of Bextra and other COX-2 inhibitors.

 

 

 

 

 

Bextra (valdecoxib), made by Pfizer, went on the market March 2002.

Doctors prescribe Bextra primarily for pain relief of osteoarthritis - a degenerative joint disease commonly affecting seniors.

Doctors also use Bextra to treat adult rheumatoid arthritis and dysmenorrhea - severe menstrual cramps.

Bextra is in a class of drugs known as the COX-2 inhibitors. A subclass of nonsteriodal anti-inflammatory drugs (NSAIDs), the COX-2 inhibitors differ from traditional NSAIDs by blocking only the enzyme which causes pain and inflammation. Vioxx and Celebrex are the other two most common COX-2 inhibitors.

 

Remember! Don't wait until it's too late! The law puts time limits on how long you can wait before bringing a case. The time limits and conditions vary from state-to-state and under Federal Law.

If you have used Bextra and suffered a heart attack, stroke, serious skin reaction or death - call or email us today for a FREE case evaluation.

Our lawyers will review the facts in your case, explain your legal rights and if we determine you have a case,